Related Experiment Video
Updated: Aug 23, 2026

Establishment and Characterization of UTI and CAUTI in a Mouse Model
Published on: June 23, 2015
Recurrent UTIs in Children With CAKUT
Lucielle Standish1, Holly Campbell1, Shehryar Saharan2
1Department of Paediatric Urology, Monash Children's Hospital, Melbourne, Australia.
Insights
Congenital kidney and urinary tract abnormalities (CAKUT) are a leading cause of childhood kidney failure. Early diagnosis and tailored management, focusing on infection prevention and renal preservation, are crucial for favorable outcomes.
Area of Science:
- Pediatric Nephrology
- Urology
- Medical Genetics
Background:
- Congenital abnormalities of the kidney and urinary tract (CAKUT) are a primary cause of kidney failure in children.
- Urinary tract dilatation is a common presentation, with conditions like posterior urethral valves (PUV) posing significant risks.
Purpose of the Study:
- To outline diagnostic and management strategies for CAKUT.
- To emphasize the importance of preventing febrile urinary tract infections (fUTIs) and preserving renal function.
Main Methods:
- Utilizes renal tract ultrasound for postnatal surveillance.
- Employs micturating cystourethrogram and nuclear scintigraphy for specific diagnostic needs.
- Reviews management approaches including surgical and endoscopic interventions, and antibiotic prophylaxis.
Main Results:
- Early diagnosis and intervention for PUV, including valve incision and antibiotic prophylaxis, reduce fUTI risk and kidney impairment.
- Management of vesicoureteric junction obstruction (VUJO) and duplex anomalies involves interventions based on fUTI risk.
- Primary vesicoureteric reflux (VUR) management focuses on bladder-bowel dysfunction treatment and selective prophylaxis.
Conclusions:
- Effective management of CAKUT requires a balance between infection prevention, renal preservation, and functional outcomes.
- Tailored approaches for specific CAKUT diagnoses are essential for optimizing pediatric kidney health.
- Routine prophylaxis is not advised for isolated unilateral hydronephrosis without distal ureteric dilatation.
Abstract:
Congenital abnormalities of the kidney and urinary tract (CAKUT) encompass diverse diagnoses that commonly present as urinary tract dilatation and are the leading cause of kidney failure in children. Antenatal hydronephrosis occurs in ~1% of pregnancies; most resolve spontaneously, but conditions such as posterior urethral valves (PUV), pelviureteric junction obstruction (PUJO), vesicoureteric junction obstruction (VUJO), duplex systems, ureteroceles, and vesicoureteric reflux (VUR) require specific approaches to diagnosis and management. Postnatal surveillance relies predominantly on renal tract ultrasound, with micturating cystourethrogram and nuclear scintigraphy used in specific scenarios to define diagnoses, confirm obstruction, and quantify differential function. Urinary tract infections (UTIs) are common and can cause significant morbidity, including sepsis and long-term scarring; prevention of febrile UTIs (fUTIs) is often a central goal. PUV is often associated with a high risk of kidney impairment and fUTI, with early diagnosis, bladder drainage, valve incision, circumcision, and antibiotic prophylaxis shown to reduce UTI risk. VUJO and duplex anomalies carry variable fUTI risk influenced by ureteric dilation and ureteroceles; endoscopic and surgical interventions are effective when indicated. Primary VUR management emphasises bladder-bowel dysfunction treatment, selective antibiotic prophylaxis, and endoscopic injection for recalcitrant fUTIs. Routine prophylaxis is not recommended for isolated unilateral hydronephrosis without distal ureteric dilatation. Management balances infection prevention, renal preservation, and functional outcomes.
Related Concept Videos
Urinary Tract Infection I: Introduction
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Calculi I: Introduction
Acute Pyelonephritis I: Introduction
Urine Studies II: Urine Culture and Sensitivity Test

